News
-
-
-
PRESS RELEASE
HBM Healthcare Investments delivers strong quarterly performance, expects profit of CHF 238 million
HBM Healthcare Investments reports strong quarterly performance with an expected profit of CHF 238 million, driven by value growth in portfolio companies and M&A activities in the biotechnology sector -
-
-
-
-
-
-
PRESS RELEASE
HBM Healthcare Investments benefits from successful IPO of Parabilis Medicines
HBM Healthcare Investments benefits from successful IPO of Parabilis Medicines, a clinical-stage biopharmaceutical company focused on developing cancer therapies. Parabilis IPO marks significant milestone in biotechnology sector